Strongbridge Biopharma plc

SBBP

$2.09

-25.4% (1 year change)

Market Cap

$142 Million

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$1.85 - $4.26

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

0.0x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $142 Million
Enterprise Value -
Dividend Yield $0.00 (0.0%)
1 Year Return -25.4%
52-Week High $4.26
52-Week Low $1.85
Beta 1.08
Outstanding Shares 67.8 Million
Avg 30 Day Volume 319 Thousand

Valuation

P/E Ratio 0.0
PEG -
Earnings per Share $0.00
Price to Sales Ratio -
Price to Book Ratio -
Revenue to Enterprise Value -
EBIT to Enterprise Value -
Total Debt to Enterprise Value -
Debt to Equity -

Profitability

Revenue -
Gross Profit -
EBIT -
Net Income -
Profit Margin -
Quarterly Earnings Growth (YoY) -
Return on Equity -
Return on Assets -
Return on Invested Capital -

News

Dynamic volume-return relation of individual stocks: The Coca-Cola Company (NYSE:KO -1.64%), Strongbridge Biopharma plc (NASDAQ:SBBP 1.44%)

Dynamic volume-return relation of individual stocks: The Coca-Cola Company (NYSE:KO -1.64%), Strongbridge Biopharma plc (NASDAQ:SBBP 1.44%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Dynamic vo...

Stock Equity Stock Equity, 3 days ago
Xeris'' rises 5% as stockholders approve Strongbridge Biopharma acquisition

Xeris'' rises 5% as stockholders approve Strongbridge Biopharma acquisition

No summary available.

Seeking Alpha Seeking Alpha, 8 days ago
Strongbridge Biopharma shareholders vote in favor of Xeris deal

Strongbridge Biopharma shareholders vote in favor of Xeris deal

No summary available.

Seeking Alpha Seeking Alpha, 14 days ago